Search

Displaying results 7091 - 7100 of 10000 in total
  1. Drug

    Iodofiltic acid I-123

    go.drugbank.com/drugs/DB05683
    Investigational

    Synonyms: I-123 BMIPP, Iodofiltic acid I 123
  2. Drug

    R-1487

    go.drugbank.com/drugs/DB06518
    Experimental

    Salts: R-1487 hydrochlorideCategories: Heterocyclic Compounds, 1-Ring
  3. Drug

    Rebastinib

    go.drugbank.com/drugs/DB13005
    Investigational

    Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  4. Drug

    GW-559090

    go.drugbank.com/drugs/DB06508
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Edaglitazone

    go.drugbank.com/drugs/DB06519
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Tramiprosate

    go.drugbank.com/drugs/DB06527
    Investigational

  7. Drug

    Dextofisopam

    go.drugbank.com/drugs/DB06582
    Investigational

    Synonyms: R-tofisopamCategories: Heterocyclic Compounds, 2-Ring
  8. Drug

    Omiganan

    go.drugbank.com/drugs/DB06610
    Investigational

    Omiganan has been investigated for the treatment of Mupirocin-resistant MRSA skin infections.

  9. Drug

    WIN 55212-2

    go.drugbank.com/drugs/DB13950
    Experimental

    It is a potent cannabinoid receptor agonist that has been found to be a potent analgesic in a rat model of neuropathic pain. It activates p42 and p44 MAP kinase via receptor-mediated signaling. … WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but has an entirely different chemical

    Salts: WIN 55212-2 mesylateCategories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-Ring
  10. Drug

    Poly(lactic acid)

    go.drugbank.com/drugs/DB15037
    ApprovedInvestigationalWithdrawn

    Poly(lactic acid) is under investigation in clinical trial NCT00126308 (Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy).

    Synonyms: POLY-L-LACTIC ACID